Company news

Schrodinger, Inc. news in 2024

Schrodinger, Inc.'s news releases, calls and decks from 2024, newest first.

View company

Schrödinger to Present at Piper Sandler 36th Annual Healthcare Conference

November 19, 2024

Schrödinger Broadens and Accelerates Predictive Toxicology Initiative

November 17, 2024

Schrödinger Reports Third Quarter 2024 Financial Results

November 11, 2024

Schrödinger Announces Multi-Target Collaboration and Expanded Software Licensing Agreement with Novartis

November 11, 2024

Schrödinger to Announce Third Quarter 2024 Financial Results on November 12

October 30, 2024

Schrödinger Presents SGR-3515 Preclinical Data at 2024 EORTC-NCI-AACR Symposium

October 22, 2024

Schrödinger to Present New Preclinical SGR-3515 and PRMT5-MTA Data at 2024 EORTC-NCI-AACR Symposium

October 8, 2024

Schrödinger Reports Strong Second Quarter 2024 Financial Results

July 30, 2024

Schrödinger Launches Initiative to Significantly Expand Application of Computational Tools for Predictive Toxicology

July 25, 2024

Schrödinger to Announce Second Quarter 2024 Financial Results on July 31

July 16, 2024

Schrödinger Reports First Quarter 2024 Financial Results

April 30, 2024

Schrödinger to Announce First Quarter 2024 Financial Results on May 1

April 9, 2024

Schrödinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National Meeting

March 19, 2024

Schrödinger Reports Strong Fourth Quarter and Full-Year 2023 Financial Results

February 27, 2024

Schrödinger to Announce Fourth Quarter and Full-Year 2023 Financial Results on February 28

February 13, 2024

Schrödinger Provides Update on Progress Across the Business and Outlines 2024 Development and Operational Goals

January 7, 2024

Calls in 2024

Decks in 2024